Prophylactic implantable cardioverter-defibrillator

• US 5,439,482 A
• Filed: 09/23/1993
• Issued: 08/08/1995
• Est. Priority Date: 04/07/1992
• Status: Expired due to Term

• Current Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Original Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Inventors: Kroll, Mark W., Adams, Theodore P.
• Primary Examiner(s): Cohen, Lee S.
• Assistant Examiner(s): Parker, Marianne
• Application Number:
  US08/126,044
• Time in Patent Office: 684 Days
• Field of Search: 607/5, 607/7, 607/36
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3912 Output circuitry therefor, e.g. switches
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence
• CPC Class Codes: H01M 16/00 Structural combinations of different types of electrochemical generators
• CPC Class Codes: H01M 6/5016 Multimode utilisation

Abstract

A practical and effective prophylactic implantable cardioverter defibrillator (ICD) that has the potential to benefit a large number of patients with less severe cardiac conditions who now lack the opportunity to be served in a practical way by existing ICD systems. Unlike existing ICD systems, the prophylactic ICD is designed to deliver between about 100 to 200 shocks, with each shock having a maximum delivered energy value of only about 25 joules. As a result, the initial stored energy requirements of the prophylactic ICD system are less than about 12,000 joules, and both the battery and the capacitor systems can be significantly smaller than existing ICD system. The smaller battery and capacitor systems produce in an implantable device having a physical size small enough to permit implantation of the device in the pectoral region. By using the particular ranges of number of shocks and maximum energy value for each shock to design the ICD system, the result is a practical prophylactic ICD system that will provide effective prophylactic therapy for prospective cardiac incidents in patients with less severe cardiac conditions.

Claims

1. A prophylactic implantable cardioverter defibrillator device for subcutaneous positioning within a pectoral region of a human patient capable of internally storing sufficient electrical energy so as to effectively treat a mildly impaired cardiac dysrhythmia condition comprising:

a sealed housing structure, having at least two walls defining an interior space therebetween the at least two walls, constructed of a biocompatible material and having a displacement volume of less than about 75 cc and including one or more connector ports disposed in a wall of said structure for providing electrical connections between said interior space of said structure and electrode leads in said patient;

circuit means, within said interior space, including;

means for sensing cardiac signals received from said electrode leads;

means for detecting and confirming a dysrhythmia in said cardiac signals; and

means for controlling delivery of one or more electrical cardioversion/defibrillation countershocks of at least 0.5 Joules to said patient in response to the detection of a dysrhythmia;

capacitor means within said interior space for storing electrical energy to generate said electrical cardioversion/defibrillation countershocks and having an effective capacitance of less than about 100 μ

F; and

battery means within said interior space for providing electrical energy to said circuit means and said capacitor means and capable of charging said capacitor means to a maximum stored electrical charge energy of less than about 27 Joules,

wherein a total amount of electrical energy stored by said battery means is less than about 12,000 Joules and a budgeted number of electrical cardioversion/defibrillation countershocks is greater than about 100 and less than about 200.

2. The device of claim 1 wherein said means for controlling delivery of defibrillation countershocks includes an inverter/output circuit to produce electrical cardioversion/defibrilation waveforms which are biphasic.

3. The device of claim 1 wherein said battery means comprises:

first battery means for providing electrical power primarily only to the circuit means for sensing cardiac conditions; and

second battery means for providing substantially all of the electrical power for charging said capacitor means.

4. The device of claim 1 wherein said battery means has a worst-case minimum charging time for charging said capacitor means to said maximum stored electrical charge that is less than about 10 seconds.

5. The device of claim 1 wherein:

said means for detecting and confirming is programmable to reconfirm a detection of a dysrhythmia following delivery of at least one countershock; and

the circuit means further includes;

means for storing a programmable therapy regimen;

means for regulating a charging voltage applied by the battery means to the capacitor means in response to a charging voltage value indicated in the programmable therapy regimen;

means for selectively discharging the capacitor means as an electrical countershock in response to a reconfirmed detection of the dysrhythmia;

means for counting a successive number of failed electrical countershocks in the programmable therapy regimen when the electrical countershock was not successful in treating the dysrhythmia; and

means for resetting the means for counting to zero after a successful treatment of a myocardial fibrillation,

wherein at least one of the charging voltage values in the programmable therapy regimen is a maximum nominal voltage and at least another of the charging voltage values in the programmable therapy regimen is an overcharged voltage greater than the maximum voltage.

6. The device of claim 5 wherein the capacitor means is a pair of electrolytic capacitors in series and the electrolytic capacitors maximal nominal voltage is at least 750 volts such that there is a maximum charging voltage value of not greater than 375 volts across each capacitor.

7. A prophylactic implantable cardioverter defibrillator device for subcutaneous positioning within a pectoral region of a human patient capable of internally storing sufficient electrical energy so as to effectively treat mildly impaired cardiac dysrhythmia conditions comprising:

a sealed housing structure, having at least two walls defining an interior space there between the at least two walls, constructed of a biocompatible material and having a displacement volume of less than about cc and including one or more connector ports disposed in a wall of said structure for providing electrical connections between said interior space of said structure and electrode leads in said patient;

circuit means, within said interior space, including;

means for sensing cardiac signals received from said electrode leads;

means for detecting and confirming a dysrhythmia in said cardiac signals; and

means for controlling delivery of one or more electrical cardioversion/defibrillation countershocks of at least 0.5 Joules to said patient in response to the detection of a dysrhythmia;

capacitor means within said interior space for storing electrical energy to generate said electrical cardioversion/defibrillation countershocks and having an effective capacitance of less than about 100 μ

F; and

battery means within said interior space for providing electrical energy to said circuit means and said capacitor means and capable of charging said capacitor means to a maximum stored electrical charge energy of less than about 21 Joules,

wherein an amount of electrical energy stored by said battery means to provide said electrical cardioversion/defibrillation countershocks is less than about 7500 Joules and a budgeted number of electrical cardioversion/defibrillation countershocks is greater than about 100 and less than about 200.

8. The device of claim 7 wherein said means for controlling delivery of defibrillation countershocks includes an inverter/output circuit to produce electrical cardioversion/defibrillation waveforms which are biphasic.

9. The device of claim 7 wherein said battery means comprises:

first battery means for providing electrical power primarily only to the circuit means for sensing cardiac conditions; and

second battery means for providing substantially all of the electrical power for charging said capacitor means.

10. The device of claim 7 wherein said battery means has a worst-case minimum charging time for charging said capacitor means to said maximum stored electrical charge that is at least about 10 seconds and less than about 15seconds.

11. The device of claim 7 wherein said circuit means comprises:

wake-up circuit means that responds to one or more wake-up conditions for the device selected from the group Of wake-up conditions consisting of;

detecting a dysrhythmia, detecting a wake-up signal external to the device, detecting a low power condition for the device, and detecting a failure condition for the device; and

microprocessor circuit means that is powered up in response to a signal from said wake-up circuit means to process said wake-up condition.

12. The device of claim 11 wherein said wake-up circuit means detects said arrhythmia by detecting whether said cardiac signals represent a heart beat of greater than about 210 bpm, such that said wake-up circuit means has an idle current requirement that is less than about 10 μ

A.

13. The device of claim 7 wherein said effective capacitance value of said capacitor means is between about 40 μ

f and 70 μ

f.

14. The device of claim 7 wherein:

said means for detecting and confirming is programmable to reconfirm a detection of a..dysrhythmia following delivery of at least one countershock; and

the circuit means further includes;

means for storing a programmable therapy regimen;

means for regulating a charging voltage applied by the battery means to the capacitor means in response to a charging voltage value indicated in the programmable therapy regimen;

means for selectively discharging the capacitor means stored electrical energy as an electrical countershock in response to a reconfirmed detection of the dysrhythmia;

means for counting a successive number of failed electrical countershocks in the programmable therapy regimen when the electrical countershock was not successful in treating the dysrhythmia; and

means for resetting the means for counting to zero after a successful treatment of a myocardial fibrillation,

wherein at least one of the charging voltage values in the programmable therapy regimen is a maximum nominal voltage and at least another of the charging voltage values in the programmable therapy regimen is an overcharged voltage greater than the maximum nominal voltage.

15. The device of claim 14 wherein the capacitor means is a pair of electrolytic capacitors in series and the electrolytic capacitors maximal nominal voltage is at least 750 volts such that there is a maximum charging voltage valise of greater than 375 volts across each capacitor.

16. A prophylactic implantable cardioverter defibrillator device for subcutaneous positioning within a pectoral region of a human patient capable of internally storing sufficient electrical energy so as to effectively treat mildly impaired cardiac dysrhythmia conditions comprising:

a sealed housing structure, having at least two walls defining an interior space the at least two walls, constructed of a biocompatible material and having a displacement volume of less than about 60 cc and including one or more connector ports disposed in a wall of said structure for providing electrical connections between said interior space of said structure and electrode leads in said patient;

circuit means, within said interior space, including;

means for sensing cardiac signals received from said electrode leads;

means for detecting and confirming a dysrhythmia in said cardiac signals; and

means for controlling delivery of one or more electrical cardioversion/defibrillation countershocks of at least 0.5 Joules to said patient in response to the detection of a dysrhythmia;

capacitor means within said interior space for storing electrical energy to generate said electrical cardioversion/defibrillation countershocks and having an effective capacitance of less than about 100 μ

F; and

battery means within said interior space for providing electrical energy to said circuit means and said capacitor means and capable of charging said capacitor means to a maximum stored electrical charge energy of less than about 21 Joules,

wherein a total amount of electrical energy stored by said battery means is less than about 10000 Joules, a budgeted number of electrical cardioversion/defibrillation countershocks is greater than about 100 and less than about 200, and the minimum lifespan of the device is less than about 3 years.

17. The device of claim 16 wherein said means for controlling delivery of defibrillation countershocks includes an inverter/output circuit to produce electrical cardioversion/defibrillation waveforms which are biphasic.

18. The device of claim 16 wherein said battery means comprises:

first battery means for providing electrical power primarily only to the circuit means for sensing cardiac conditions; and

second battery means for providing substantially all of the electrical power for charging said capacitor means.

19. The device of claim 16 wherein said battery means has a worst-case minimum charging time for charging said capacitor means to said maximum stored electrical charge that is at least about 10 seconds and less than about 15 seconds.

20. The device of claim 16 wherein said circuit means comprises:

wake-up circuit means that responds to one or more wake-up conditions for the device selected from the group of wake-up conditions consisting of;

detecting a dysrhythmia, detecting a wake-up signal external to the device, detecting a low power condition for the device, and detecting a failure condition for the device; and

microprocessor circuit means that is powered up in response to a signal from said wake-up circuit means to process said wake-up condition.

21. The device of claim 20 wherein said wake-up circuit means detects said arrhythmia by detecting whether said cardiac signals represent a heart beat of greater than about 210 bpm, such that said wake-up circuit means has an idle current requirement that is less than about 10 μ

A.

22. The device of claim 16 wherein said effective capacitance value of said capacitor means is between about 40 μ

f and 70 μ

f.

23. The device of claim 16 wherein:

said means for detecting and confirming is programmable to reconfirm a detection of dysrhythmia following delivery of at least one countershock; and

the circuit means further includes;

means for storing a programmable therapy regimen;

means for regulating a charging voltage applied by the battery means to the capacitor means in response to a charging voltage value indicated in a programmable therapy regimen;

means for selectively discharging the capacitor means stored electrical energy as an electrical countershock in response to a reconfirmed detection of the dysrhythmia;

means for counting a successive number of failed electrical countershocks in the programmable therapy regimen when the electrical countershock was not successful in treating the dysrhythmia; and

means for resetting the means for counting to zero after a successful treatment of a myocardial fibrillation,

wherein at least one of the charging voltage values in the programmable therapy regimen is a maximum nominal voltage and at least another of the charging voltage values in the programmable therapy regimen is an overcharged voltage greater than the maximum voltage.

24. The device of claim 23 wherein the capacitor means is a pair of electrolytic capacitors in series and the electrolytic capacitors maximal nominal voltage is at least 750 volts such that there is a maximum charging voltage value of greater than 375 volts across each capacitor.